Hangzhou Alltest Biotech Co., Ltd.
Shanghai Stock Exchange 688606.SS
Hangzhou Alltest Biotech Co., Ltd. Total Assets for the year ending December 31, 2023: USD 579.75 M
Hangzhou Alltest Biotech Co., Ltd. Total Assets is USD 579.75 M for the year ending December 31, 2023, a -14.87% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Hangzhou Alltest Biotech Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 681.04 M, a 7.96% change year over year.
-
Hangzhou Alltest Biotech Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 630.83 M, a 257.72% change year over year.
-
Hangzhou Alltest Biotech Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 176.35 M, a 269.34% change year over year.
-
Hangzhou Alltest Biotech Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 47.75 M, a 29.00% change year over year.
Key data
| Date | Total Assets | Current Liabilities | Total Non-Current Liabilities | Shareholders' Equity |
|---|
Market news
Loading...
Shanghai Stock Exchange: 688606.SS
| CEO | Mr. Fei Gao |
| IPO Date | March 25, 2021 |
| Location | China |
| Headquarters | #550, Yinhai Street |
| Employees | 1,093 |
| Sector | Health Care |
| Industries | |
Description
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and market of in vitro diagnostic reagents worldwide. It offers rapid diagnostic products, including women's health, infectious diseases, drugs, cancer, cardiovascular, and other five series of products. The company is based in Hangzhou, China.
Key trends
Past 5 years
Similar companies
Intco Medical Technology Co., Ltd.
USD 3.37
3.57%
Gan & Lee Pharmaceuticals.
USD 5.86
3.13%
Zhonghong Pulin Medical Products Co., Ltd.
USD 1.71
3.98%
Zhejiang Orient Gene Biotech Co., Ltd.
USD 3.93
2.90%
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
USD 2.46
1.36%
StockViz Staff
January 15, 2025
Any question? Send us an email